(Q33786137)

English

Vascular endothelial growth factor receptor 2 (VEGFR-2) signalling activity in paediatric pilocytic astrocytoma is restricted to tumour endothelial cells.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Vascular endothelial growth factor receptor 2 (VEGFR-2) signalling activity in paediatric pilocytic astrocytoma is restricted to tumour endothelial cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

pilocytic astrocytoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Maikel P Peppelenbosch

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

A H Sikkema

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

E S J M de Bont

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

P J Zwiers

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

S H Diks

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

E W Hoving

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

W A Kamps

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

W F A den Dunnen

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Neuropathology and Applied Neurobiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

538-548

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208252%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

From the archives of the AFIP: pilocytic astrocytoma: radiologic-pathologic correlation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Long-term outcome after resection of benign cerebellar astrocytomas in children and young adults (0-19 years): report of 110 consecutive cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Pilocytic astrocytomas in children: prognostic factors--a retrospective study of 80 cases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Cerebellar pilocytic astrocytoma: a treatment protocol based upon analysis of 73 cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Tumour vasculature and angiogenic profile of paediatric pilocytic astrocytoma; is it much different from glioblastoma?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

A small molecule-kinase interaction map for clinical kinase inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Kinome profiling in pediatric brain tumors as a new approach for target discovery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Analysis of in vivo endothelial cell activation applying RT-PCR following endothelial cell isolation by laser dissection microscopy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Evidence based selection of housekeeping genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Direct observation of individual endogenous protein complexes in situ by proximity ligation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Heterogeneity of endothelial cells. Specific markers.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Compassionate use of bevacizumab (Avastin) in children and young adults with refractory or recurrent solid tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Autocrine pathways of the vascular endothelial growth factor (VEGF) in glioblastoma multiforme: clinical relevance of radiation-induced increase of VEGF levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Vascular endothelial growth factor C induces angiogenesis in vivo.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Molecular mechanisms of lymphangiogenesis in health and disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Angiogenic profile of breast carcinoma determines leukocyte infiltration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Vascular endothelial growth factor-C and vascular endothelial growth factor-d messenger RNA expression in breast cancer: association with lymph node metastasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

VEGFR-3 in adult angiogenesis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Expression of VEGFR3 in glioma endothelium correlates with tumor grade.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Heterodimerization with vascular endothelial growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3 activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Modulation of VEGFR-2-mediated endothelial-cell activity by VEGF-C/VEGFR-3.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

VEGF receptor signalling - in control of vascular function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

VEGF receptor protein-tyrosine kinases: structure and regulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Pseudoprogression and pseudoresponse in the treatment of gliomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01160.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33786137&oldid=1972543893"